The burden of persistent symptom diagnoses in primary care patients: a cross-sectional study

References

• Thomas H, Mitchell G, Rich J, et al. Definition of whole person care in general practice in the english language literature: a systematic review. BMJ Open. 2018;8(12):e023758. doi: 10.1136/bmjopen-2018-023758.
   PubMed Web of Science ®Google Scholar
• Roenneberg C, et al. Functional somatic symptoms. Dtsch Arztebl Int. 2019;116(33–34):553–560.
   PubMed Web of Science ®Google Scholar
• Olde Hartman TC, Rosendal M, Aamland A, et al. What do guidelines and systematic reviews tell us about the management of medically unexplained symptoms in primary care? BJGP Open. 2017;1(3):bjgpopen17X101061. doi: 10.3399/bjgpopen17X101061.
   PubMedGoogle Scholar
• Henningsen P. Management of somatic symptom disorder. Dialogues Clin Neurosci. 2018;20(1):23–31. doi: 10.31887/DCNS.2018.20.1/phenningsen.
   PubMed Web of Science ®Google Scholar
• Bartel A, Jordan J, Correll D, et al. Somatic burden and perceived cognitive problems in trauma-exposed adults with posttraumatic stress symptoms or pain. J Clin Psychol. 2020;76(1):146–160. doi: 10.1002/jclp.22855.
   PubMed Web of Science ®Google Scholar
• Barends H, van der Wouden JC, Claassen-van Dessel N, et al. Potentially traumatic events, social support and burden of persistent somatic symptoms: a longitudinal study. J Psychosom Res. 2022;159:110945. doi: 10.1016/j.jpsychores.2022.110945.
   PubMed Web of Science ®Google Scholar
• Bradley C, Speight J. Patient perceptions of diabetes and diabetes therapy: assessing quality of life. Diabetes Metab Res Rev. 2002;18 Suppl 3:S64–S9. doi: 10.1002/dmrr.279.
   PubMed Web of Science ®Google Scholar
• Singh R, Teel C, Sabus C, et al. Fatigue in type 2 diabetes: impact on quality of life and predictors. PLOS One. 2016;11(11):e0165652. doi: 10.1371/journal.pone.0165652.
   PubMed Web of Science ®Google Scholar
• Carvalho MVd, Siqueira LB, Sousa ALL, et al. The influence of hypertension on quality of life. Arq Bras Cardiol. 2013;100(2):164–174. doi: 10.5935/abc.20130030.
   PubMed Web of Science ®Google Scholar
• Soler JK, Okkes I. Reasons for encounter and symptom diagnoses: a superior description of patients’ problems in contrast to medically unexplained symptoms (MUS). Fam Pract. 2012;29(3):272–282. doi: 10.1093/fampra/cmr101.
   PubMed Web of Science ®Google Scholar
• Freeman T, Stewart M. Making the case for the study of symptoms in family practice. Can Fam Physician. 2020;66(3):218–219.
   PubMed Web of Science ®Google Scholar
• Chaabouni A, Houwen J, Walraven I, et al. Patients’ characteristics and general practitioners’ management of patients with symptom diagnoses. J Am Board Fam Med. 2023;36(3):477–492. doi: 10.3122/jabfm.2022.220335R1.
   PubMed Web of Science ®Google Scholar
• Anderson J, O Moore K, Faraj M, et al. Stepped care mental health service in Australian primary care: codesign and feasibility study. Aust Health Rev. 2020;44(6):873–879. doi: 10.1071/AH19078.
   PubMed Web of Science ®Google Scholar
• Wortman MSH, van der Wouden JC, Twisk JWR, et al. Effectiveness of psychosomatic therapy for patients with persistent somatic symptoms: results from the CORPUS randomised controlled trial in primary care. J Psychosom Res. 2023;167:111178. doi: 10.1016/j.jpsychores.2023.111178.
   PubMed Web of Science ®Google Scholar
• van Dessel N, den Boeft M, van der Wouden JC, et al. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database Syst Rev. 2014;(11):CD011142. https://doi.org/10.1002/14651858.CD011142.pub2
   PubMed Web of Science ®Google Scholar
• Ridsdale L, et al. Chronic fatigue in general practice: is counselling as good as cognitive behaviour therapy? A UK randomised trial. Br J Gen Pract. 2001;51(462):19–24.
   PubMed Web of Science ®Google Scholar
• Sitnikova K, Pret-Oskam R, Dijkstra-Kersten SMA, et al. Management of patients with persistent medically unexplained symptoms: a descriptive study. BMC Fam Pract. 2018;19(1):88. doi: 10.1186/s12875-018-0791-9.
   PubMedGoogle Scholar
• Joustra ML, Janssens KAM, Bültmann U, et al. Functional limitations in functional somatic syndromes and well-defined medical diseases. Results from the general population cohort LifeLines. J Psychosom Res. 2015;79(2):94–99. doi: 10.1016/j.jpsychores.2015.05.004.
   PubMed Web of Science ®Google Scholar
• Luijks H, van Boven K, Olde Hartman T, et al. Purposeful incorporation of patient narratives in the medical record in The Netherlands. J Am Board Fam Med. 2021;34(4):709–723. doi: 10.3122/jabfm.2021.04.200609.
   PubMed Web of Science ®Google Scholar
• van Boven K, Uijen AA, van de Wiel N, et al. The diagnostic value of the patient’s reason for encounter for diagnosing cancer in primary care. J Am Board Fam Med. 2017;30(6):806–812. doi: 10.3122/jabfm.2017.06.170076.
   PubMed Web of Science ®Google Scholar
• Napel HT, van Boven K, Olagundoye OA, et al. Improving primary health care data with ICPC-3: from a medical to a person-centered perspective. Ann Fam Med. 2022;20(4):358–361. doi: 10.1370/afm.2830.
   PubMed Web of Science ®Google Scholar
• Rosmalen JGM, Burton C, Carson A, et al. The european training network ETUDE (encompassing training in functional disorders across Europe): a new research and training program of the EURONET-SOMA network recruiting 15 early stage researchers. J Psychosom Res. 2021;141:110345. doi: 10.1016/j.jpsychores.2020.110345.
   PubMed Web of Science ®Google Scholar
• Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64(2):258–266. doi: 10.1097/00006842-200203000-00008.
   PubMed Web of Science ®Google Scholar
• Rief W, Burton C, Frostholm L, et al. Core outcome domains for clinical trials on somatic symptom disorder, bodily distress disorder, and functional somatic syndromes: european network on somatic symptom disorders recommendations. Psychosom Med. 2017;79(9):1008–1015. doi: 10.1097/PSY.0000000000000502.
   PubMed Web of Science ®Google Scholar
• van Steenbergen-Weijenburg KM, de Vroege L, Ploeger RR, et al. Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics. BMC Health Serv Res. 2010;10(1):235. doi: 10.1186/1472-6963-10-235.
   PubMed Web of Science ®Google Scholar
• Donker T, van Straten A, Marks I, et al. Quick and easy self-rating of generalized anxiety disorder: validity of the dutch web-based GAD-7, GAD-2 and GAD-SI. Psychiatry Res. 2011;188(1):58–64. doi: 10.1016/j.psychres.2011.01.016.
   PubMed Web of Science ®Google Scholar
• Mols F, Pelle AJ, Kupper N. Normative data of the SF-12 health survey with validation using postmyocardial infarction patients in the dutch population. Qual Life Res. 2009;18(4):403–414. doi: 10.1007/s11136-009-9455-5.
   PubMed Web of Science ®Google Scholar
• M MV, et al. Dutch tariff for the five-level version of EQ-5D. Value Health. 2016;19(4):343–352.
   PubMed Web of Science ®Google Scholar
• Nieboer AP, Cramm JM. How do older people achieve well-being? Validation of the social production function instrument for the level of well-being-short (SPF-ILs). Soc Sci Med. 2018;211:304–313. doi: 10.1016/j.socscimed.2018.06.036.
   PubMed Web of Science ®Google Scholar
• Engle GL. The need for a new medical model: a challenge for biomedicine. Science, 1977;196(4286), 129–136.
   Google Scholar
• Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi: 10.1046/j.1525-1497.2001.016009606.x.
   PubMed Web of Science ®Google Scholar
• Spitzer RL, Kroenke K, Williams JBW, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–1097. doi: 10.1001/archinte.166.10.1092.
   PubMed Web of Science ®Google Scholar
• Ware J, Jr., Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220–233. doi: 10.1097/00005650-199603000-00003.
   PubMed Web of Science ®Google Scholar
• Herdman M, Gudex C, Lloyd A, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–1736. doi: 10.1007/s11136-011-9903-x.
   PubMed Web of Science ®Google Scholar
• Kocalevent R-D, Hinz A, Brähler E. Standardization of a screening instrument (PHQ-15) for somatization syndromes in the general population. BMC Psychiatry. 2013;13(1):91. doi: 10.1186/1471-244X-13-91.
   PubMedGoogle Scholar
• Hinz A, Ernst J, Glaesmer H, et al. Frequency of somatic symptoms in the general population: normative values for the patient health questionnaire-15 (PHQ-15). J Psychosom Res. 2017;96:27–31. doi: 10.1016/j.jpsychores.2016.12.017.
   PubMed Web of Science ®Google Scholar
• Nordin S, Palmquist E, Nordin M. Psychometric evaluation and normative data for a Swedish version of the patient health questionnaire 15-item somatic symptom severity scale. Scand J Psychol. 2013;54(2):112–117. doi: 10.1111/sjop.12029.
   PubMed Web of Science ®Google Scholar
• den Boeft M, van der Wouden JC, Rydell-Lexmond TR, et al. Identifying patients with medically unexplained physical symptoms in electronic medical records in primary care: a validation study. BMC Fam Pract. 2014;15(1):109. doi: 10.1186/1471-2296-15-109.
   PubMedGoogle Scholar
• Steinbrecher N, Hiller W. Course and prediction of somatoform disorder and medically unexplained symptoms in primary care. Gen Hosp Psychiatry. 2011;33(4):318–326. doi: 10.1016/j.genhosppsych.2011.05.002.
   PubMed Web of Science ®Google Scholar
• König BH, van Jaarsveld CH, Bischoff EW, et al. Prognostic factors for persistent fatigue after COVID-19: a prospective matched cohort study in primary care. Br J Gen Pract. 2023;73(730):e340–e347. doi: 10.3399/BJGP.2022.0158.
   PubMed Web of Science ®Google Scholar
• Coe R. It’s the effect size, stupid: what effect size is and why it is important. Durham: Centre for Evaluation and Monitoring. 2022.
   Google Scholar
• Dirkzwager AJ, Verhaak PF. Patients with persistent medically unexplained symptoms in general practice: characteristics and quality of care. BMC Fam Pract. 2007;8(1):33. doi: 10.1186/1471-2296-8-33.
   PubMedGoogle Scholar
• Zonneveld LNL, Sprangers MAG, Kooiman CG, et al. Patients with unexplained physical symptoms have poorer quality of life and higher costs than other patient groups: a cross-sectional study on burden. BMC Health Serv Res. 2013;13(1):520. doi: 10.1186/1472-6963-13-520.
   PubMedGoogle Scholar
• Löwe B, Spitzer RL, Williams JB, et al. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen Hosp Psychiatry. 2008;30(3):191–199. doi: 10.1016/j.genhosppsych.2008.01.001.
   PubMed Web of Science ®Google Scholar
• Feder A, Olfson M, Gameroff M, et al. Medically unexplained symptoms in an urban general medicine practice. Psychosomatics. 2001;42(3):261–268. doi: 10.1176/appi.psy.42.3.261.
   PubMed Web of Science ®Google Scholar
• Short H, Al Sayah F, Ohinmaa A, et al. The performance of the EQ-5D-3L in screening for anxiety and depressive symptoms in hospital and community settings. Health Qual Life Outcomes. 2021;19(1):96. doi: 10.1186/s12955-021-01731-x.
   PubMed Web of Science ®Google Scholar
• Koch H, van Bokhoven MA, ter Riet G, et al. Demographic characteristics and quality of life of patients with unexplained complaints: a descriptive study in general practice. Qual Life Res. 2007;16(9):1483–1489. doi: 10.1007/s11136-007-9252-y.
   PubMed Web of Science ®Google Scholar
• Bandura A. Perceived self-efficacy in cognitive-development and functioning. Educational Psychologist. 1993;28(2):117–148. doi: 10.1207/s15326985ep2802_3.
   Web of Science ®Google Scholar
• Pohontsch NJ, Zimmermann T, Jonas C, et al. Coding of medically unexplained symptoms and somatoform disorders by general practitioners - an exploratory focus group study. BMC Fam Pract. 2018;19(1):129. doi: 10.1186/s12875-018-0812-8.
   PubMed Web of Science ®Google Scholar
• Claassen-van Dessel N, et al. The 2-year course of medically unexplained physical symptoms (MUPS) in terms of symptom severity and functional status: results of the PROSPECTS cohort study. J Psychosom Res. 2018;104:76–87.
   PubMed Web of Science ®Google Scholar
• Schers H, van Weel C, van Boven K, et al. The COVID-19 pandemic in nijmegen, The Netherlands: changes in presented health problems and demand for primary care. Ann Fam Med. 2021;19(1):44–47. doi: 10.1370/afm.2625.
   PubMed Web of Science ®Google Scholar
• van de Lisdonk EH. Perceived and presented morbidity in general practice. A study with diaries in four general practices in The Netherlands. Scand J Prim Health Care. 1989;7(2):73–78. doi: 10.3109/02813438909088650.
   PubMedGoogle Scholar
• Fujii T, Oka H, Katsuhira J, et al. Association between somatic symptom burden and health-related quality of life in people with chronic low back pain. PLOS One. 2018;13(2):e0193208. doi: 10.1371/journal.pone.0193208.
   PubMed Web of Science ®Google Scholar
• Rask MT, Rosendal M, Fenger-Grøn M, et al. Sick leave and work disability in primary care patients with recent-onset multiple medically unexplained symptoms and persistent somatoform disorders: a 10-year follow-up of the FIP study. Gen Hosp Psychiatry. 2015;37(1):53–59. doi: 10.1016/j.genhosppsych.2014.10.007.
   PubMed Web of Science ®Google Scholar
• de Haan S. Bio-psycho-social interaction: an enactive perspective. Int Rev Psychiatry. 2021;33(5):471–477. doi: 10.1080/09540261.2020.1830753.
   PubMed Web of Science ®Google Scholar